Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Open in API
Filings indexed 1,585 across all filing types
Latest filing 2018-07-13 Capital/Financing Update
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 10, 2018, reporting the entry into a material definitive agreement related to an underwriting agreement for a public offering of common stock. It details the terms of the offering, the number of shares, pricing, and expected proceeds. It also includes references to exhibits such as the underwriting agreement and legal opinions. The content focuses on a financing transaction and capital raising activity, not on financial results, management changes, or other report types. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length (6324 characters) and detailed content support this classification with high confidence.
2018-07-13 English
424B5 Filing
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying prospectus for an offering of common stock by Natera, Inc. It includes details about the offering, underwriting, risk factors, use of proceeds, and other related information. The document is filed pursuant to Rule 424(b)(5) and is part of a registration statement. It is not a financial report, earnings release, or management discussion, but rather a capital raising document describing the terms and conditions of a stock offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, underwriting discounts, and legal disclaimers typical of a prospectus supplement for a financing event.
2018-07-12 English
424B5 Filing
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement dated July 10, 2018, related to an offering of common stock by Natera, Inc. It includes details about the offering, underwriting, risk factors, use of proceeds, and legal matters. The text references a registration statement on Form S-3 and is clearly a disclosure document for a capital raising event. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a report publication announcement but the actual offering document. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2018-07-10 English
4 Filing
Director's Dealing
2018-07-05 English
8-K Filing
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 27, 2018, by Natera, Inc. It announces an upcoming investor call and provides an investor presentation as Exhibit 99.1. The text explicitly states that the investor presentation is furnished as an exhibit and incorporated by reference, indicating this document is primarily an announcement of the investor presentation rather than the presentation itself. The document length is 4042 characters, which is relatively short and consistent with an announcement rather than a full report. The key phrase 'investor presentation is furnished herewith as Exhibit 99.1' and the description of the event as a 'Current Report' under Regulation FD Disclosure further support classification as an Investor Presentation filing. Therefore, the document is best classified as an Investor Presentation (IP).
2018-06-27 English
4 Filing
Director's Dealing
2018-06-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.